IBKR (IBKR)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 4/9, Altman Z 0.7.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics reveal a distinct capital efficiency profile where an ROIC of 15.4% suggests robust value generation, yet the DuPont decomposition indicates this return is driven almost entirely by high financial leverage rather than operational productivity or margin expansion; specifically, equity turnover sits at just 0.05x while margins remain healthy at 9.6%. Credit risk metrics present a contradictory signal: an Altman Z-Score of 0.7 flags potential distress territory despite the company's pristine Beneish M-Score of -2.32 and moderate Piotroski F-Score of 4/9, suggesting management earnings quality appears intact but solvency buffers are thin relative to industry norms. This structural reliance on leverage creates a scenario where equity returns are amplified by debt magnification rather than organic asset growth.
Valuation metrics currently reflect aggressive growth expectations that may not align with the underlying operational velocity; trading at 30.0x forward earnings, the stock commands a premium significantly above typical utility-like multiples for firms with such low asset turnover. While the DCF model implies a fair value of $1,258 based on assumed growth trajectories, this target price assumes execution capabilities consistent with high-growth tech peers rather than a mature financial intermediary. The market appears to be pricing in sustained acceleration that contrasts sharply with the reported 9.7% revenue growth and minimal asset efficiency, creating a divergence between current valuation premiums and fundamental operating characteristics.
Risk assessment is complicated by divergent data points; while insider activity shows substantial net selling of over $30 million within the last ninety days, potentially signaling management caution regarding near-term catalysts or liquidity needs, the low Beneish M-Score mitigates concerns about aggressive accounting manipulation. The combination of a distress-level Altman Z-Score and significant insider outflows warrants scrutiny regarding capital structure sustainability despite strong gross margins nearing 90%. Investors must weigh whether the high leverage driving ROE is a temporary strategic phase or an inherent risk that could compress equity value if revenue growth fails to meet the elevated DCF assumptions embedded in current pricing.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 8% | 10% | 12% |
|---|---|---|---|
| 2% | $1537 | $1127 | $883 |
| 3% | $1800 | $1258 | $959 |
| 4% | $2196 | $1433 | $1054 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=10.0%, terminal growth 3%. Fair value $1258 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XLF or VFH, the fund manager is mechanically forced to buy or sell IBKR shares regardless of IBKR's individual fundamentals. We estimate $4.5B of passive capital is structurally linked to IBKR through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in IBKR to visualize passive redemption contagion across ETFs and collateral stocks.
If IBKR (IBKR) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies NVIDIA Corp. (NVDA) as the most exposed collateral stock, sharing 2 ETFs with IBKR. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 31 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
IBKR Ownership Dynamics
ETFs with Highest IBKR Exposure
Float lock-up computed from 31 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
IBKR Capital Efficiency
How efficiently does IBKR convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
IBKR converts 173% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-14 | 6,301 | $85.12 | $536,341.12 |
| 2026-05-13 | 6,500 | $84.59 | $549,835 |
| 2026-05-11 | 16,782 | $84.42 | $1.4M |
| 2026-05-08 | 529 | $83.71 | $44,282.59 |
| 2026-05-05 | 2,135 | $81.72 | $174,472.2 |
| 2026-05-04 | 99 | $80.46 | $7,965.54 |
| 2026-04-29 | 4 | $77.49 | $309.96 |
| 2026-04-27 | 1,695 | $76.62 | $129,870.9 |
| 2026-04-24 | 853 | $75.90 | $64,742.7 |
| 2026-04-22 | 12,211 | $79.62 | $972,239.82 |
| 2026-04-21 | 12,340 | $81.25 | $1.0M |
| 2026-04-20 | 307 | $81.71 | $25,084.97 |
| 2026-04-17 | 95 | $79.38 | $7,541.1 |
| 2026-04-16 | 6 | $79.69 | $478.14 |
| 2026-04-15 | 3 | $77.10 | $231.3 |
| 2026-04-14 | 1 | $74.55 | $74.55 |
| 2026-04-13 | 12,408 | $71.21 | $883,573.68 |
| 2026-04-10 | 13,242 | $71.93 | $952,497.06 |
| 2026-04-08 | 1,092 | $68.11 | $74,376.12 |
| 2026-04-01 | 77 | $67.07 | $5,164.39 |
| 2026-03-31 | 2,420 | $63.69 | $154,129.8 |
| 2026-03-27 | 9 | $66.20 | $595.8 |
| 2026-03-25 | 45 | $66.12 | $2,975.4 |
| 2026-03-23 | 10 | $65.47 | $654.7 |
| 2026-03-20 | 1,384 | $67.69 | $93,682.96 |
| 2026-03-16 | 80 | $66.19 | $5,295.2 |
| 2026-03-13 | 714 | $66.92 | $47,780.88 |
| 2026-03-05 | 20 | $69.15 | $1,383 |
| 2026-02-23 | 800 | $74.40 | $59,520 |
| 2026-02-20 | 5,453 | $73.99 | $403,467.47 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare IBKR to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.